POET Technologies Reports Second Quarter 2024 Financial Results
TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the […]
TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the […]
HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — BIO-key®International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity […]
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) — Biofrontera Inc. (NASDAQ:BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of […]
BOSTON and ATLANTA, Aug. 14, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical […]
LANGHORNE, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of […]
Monotherapy activity of long duration in patients who have progressed on checkpoint therapy via a novel immuno-oncology mechanism of action […]
Presented Positive Interim ReSPECT-LM Phase 1 Data for Rhenium (186Re) Obisbemeda for Leptomeningeal MetastasesPresented Positive Topline Clinical Trial Results for […]
LONDON, Aug. 14, 2024 (GLOBE NEWSWIRE) — Financial Highlights On August 14, 2024, the Board of Navigator Holdings Ltd. (NYSE: […]
HOUSTON, Aug. 14, 2024 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial […]
SAN FRANCISCO, Aug. 14, 2024 (GLOBE NEWSWIRE) — LiveRamp® (NYSE: RAMP), the leading data collaboration platform, today announced that its […]